WallStreetZenWallStreetZen
Analyst Ranking
Top 1%
#21 out of 4174 analysts
Average Return
+45.82%
Win Rate
64%37 out of 58
Risk vs Reward
Poor
Good

Derek Archila's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cabaletta Bio IncCABA
+1,308.47%$0.87$12.31
2022-09-13 -
2023-02-03
Strong Buy
Prometheus Biosciences IncRXDX
+294.91%$27.52$108.68
2022-05-12 -
2023-02-03
Strong Buy
Prometheus Biosciences IncRXDX
+185.97%$33.50$95.80
2021-12-07 -
2022-12-07
Strong Buy
Ngm Biopharmaceuticals IncNGM
+167.08%$11.30$30.18
2020-03-18 -
2021-03-19
Strong Buy
Rhythm Pharmaceuticals IncRYTM
+164.83%$10.35$27.41
2021-12-07 -
2022-12-07
Strong Buy

Derek Archila's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Kymera Therapeutics IncKYMR
4Strong Buy$42.00+13.06%Maintains
a month ago
Kezar Life Sciences IncKZR
6Strong Buy$14.00+97.18%Maintains
a month ago
Incyte CorpINCY
3Hold$75.00-10.30%Maintains
a month ago
Cabaletta Bio IncCABA
3Strong Buy$14.00+13.73%Maintains
a month ago
C4 Therapeutics IncCCCC
3Hold$9.00+30.25%Maintains
a month ago
Ascendis Pharma AASND
6Strong Buy$177.00+52.45%Maintains
a month ago
Apellis Pharmaceuticals IncAPLS
3Hold$58.00+5.90%Downgrades
a month ago
Arvinas IncARVN
2Hold$49.00+39.60%Downgrades
a month ago
Monte Rosa Therapeutics IncGLUE
2Strong Buy$19.00+131.43%Upgrades
a month ago
Blueprint Medicines CorpBPMC
2Hold$41.00-10.19%Upgrades
a month ago
Immunovant IncIMVT
6Strong Buy$27.00+52.11%Upgrades
a month ago
Horizon Therapeutics Public Ltd CoHZNP
2Hold$116.50+6.22%Downgrades
2 months ago
Morphic Holding IncMORF
4Strong Buy$78.00+125.76%Maintains
3 months ago
Argenx SeARGX
3Strong Buy$469.00+26.43%Maintains
4 months ago
Prometheus Biosciences IncRXDX
4Strong Buy$71.00-34.67%Maintains
5 months ago
Nurix Therapeutics IncNRIX
3Strong Buy$25.00+99.68%Upgrades
8 months ago
Zentalis Pharmaceuticals IncZNTL
1Strong Buy$67.00+187.68%Initiates Coverage On
10 months ago
Arena Pharmaceuticals IncARNA
1Strong Buy$71.00N/AInitiates Coverage On
a year ago
Rhythm Pharmaceuticals IncRYTM
1Strong Buy$30.00N/AInitiates Coverage On
a year ago
Esperion Therapeutics IncESPR
1Hold$20.00N/ADowngrades
2 years ago
Lumos Pharma IncLUMO
1Strong Buy$24.00N/AUpgrades
2 years ago
Momenta Pharmaceuticals IncMNTA
2Hold$52.50N/ADowngrades
2 years ago
Principia Biopharma IncPRNB
1Hold$100.00N/ADowngrades
2 years ago
Inventiva SaIVA
1Strong Buy$18.00N/AInitiates Coverage On
3 years ago
Genfit SaGNFT
1Strong BuyN/AN/AUpgrades
3 years ago
Galapagos NvGLPG
1Hold$193.00N/ADowngrades
3 years ago
Viela Bio IncVIE
1Hold$58.00N/AInitiates Coverage On
3 years ago
Cymabay Therapeutics IncCBAY
1Strong Buy$8.00N/AUpgrades
3 years ago
Oneok IncOKE
1Strong Buy$41.00N/AReiterates
3 years ago
Amarin Corp PLCAMRN
2Hold$8.00N/AMaintains
3 years ago
Ngm Biopharmaceuticals IncNGM
1Strong Buy$32.00N/AMaintains
3 years ago
Dbv Technologies SaDBVT
2Hold$6.00N/ADowngrades
3 years ago
Vanda Pharmaceuticals IncVNDA
4Hold$29.00N/ADowngrades
4 years ago
Heron Therapeutics IncHRTX
2Buy$50.00N/AMaintains
5 years ago
Urogen Pharma LtdURGN
1Buy$51.00N/AMaintains
5 years ago
Perrigo Co PLCPRGO
1Buy$88.00N/AInitiates Coverage On
5 years ago
Pacira Biosciences IncPCRX
1HoldN/AN/AInitiates Coverage On
5 years ago
Zynerba Pharmaceuticals IncZYNE
1HoldN/AN/ADowngrades
5 years ago
Teva Pharmaceutical Industries LtdTEVA
1HoldN/AN/ADowngrades
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.